4.7 Article

Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User's Guide for Adult and Pediatric Gastroenterologists

Manasi Agrawal et al.

Summary: Inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, are chronic, progressive, immune-mediated diseases of adults and children with no cure. Delay in diagnosis is common and associated with adverse outcomes, highlighting the importance of early diagnosis and prompt treatment. Risk stratification based on clinical, demographic, and serologic markers can guide selection of first-line therapy in personalized medicine.

GASTROENTEROLOGY (2021)

Review Immunology

Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice

Stefano Bruscoli et al.

Summary: Inflammatory bowel disease (IBD) comprises ulcerative colitis (UC) and Crohn's disease (CD) and involves immune cell alteration and chronic inflammatory cascade activation against unknown environmental triggers. Therapy focuses on supporting measures and use of anti-inflammatory and immunosuppressive drugs, with glucocorticoids (GCs) being a cornerstone treatment for moderate-to-severe IBD. However, their use is limited by important adverse drug effects, leading researchers to explore newer, safer alternatives.

FRONTIERS IN IMMUNOLOGY (2021)

Review Gastroenterology & Hepatology

Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment

Xiao Yan Guo et al.

JOURNAL OF DIGESTIVE DISEASES (2020)

Article Gastroenterology & Hepatology

Vitamin D Inhibits Pro-Inflammatory T Cell Function in Patients With Inflammatory Bowel Disease

Josefine Schardey et al.

JOURNAL OF CROHNS & COLITIS (2019)

Article Medicine, General & Internal

Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis A Randomized Clinical Trial

Samuel P. Costello et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Gastroenterology & Hepatology

ACG Clinical Guideline: Ulcerative Colitis in Adults

David T. Rubin et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

Marcus Harbord et al.

JOURNAL OF CROHNS & COLITIS (2017)

Review Gastroenterology & Hepatology

Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology

Karen Dubois-Camacho et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

Noortje G. Rossen et al.

GASTROENTEROLOGY (2015)

Review Gastroenterology & Hepatology

Immunoregulatory Pathways Involved in Inflammatory Bowel Disease

Gabriela Fonseca-Camarillo et al.

INFLAMMATORY BOWEL DISEASES (2015)

Article Gastroenterology & Hepatology

What are the factors that affect hospitalization and surgery for aggravation of ulcerative colitis?

Satohiro Matsumoto et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Role of serum cytokine profile in ulcerative colitis assessment

Manuel Luis Rodriguez-Peralvarez et al.

INFLAMMATORY BOWEL DISEASES (2012)

Article Gastroenterology & Hepatology

Ulcerative colitis:: Patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort

Ole Hoie et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)

Article Immunology

Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis

S Melgar et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)